Aftab A. Ansari, Ann E. Mayne, Nattawat Onlamoon, Kovit Pattanapanyasat, Kazuyasu Mori, Francois Villinger Use of recombinant cytokines for optimized induction of antiviral immunity against SIV in the nonhuman primate model of human AIDS. Immunologic Research. Vol.29, No.1-3 (2004), 1-17. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21369
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Use of recombinant cytokines for optimized induction of antiviral immunity against SIV in the nonhuman primate model of human AIDS
Outbreaks of infectious diseases such as HIV and the much televised and attention-getting outbreaks of diseases such as Ebola, Hantaviruses, and the most recent outbreak of SARS have induced a significant new interest in the formulations and more importantly the science of vaccinology, which has previously to a large extent been conducted empirically. Our laboratory has focused on the use of recombinant nonhuman primate cytokines as adjunctive therapies for inducing antigen-specific immune responses in monkeys because most recombinant human cytokines appear to be immunogenic. This article provides a summary of our work with such cytokines, which includes attempts to define optimum dosing schedules that lead to optimal primary and lasting memory antigen-specific immune responses.
